Latest Period
Q2 2026
Security Snapshot
PROKIDNEY CORP. - Class A Common Stock (PROK) Institutional Ownership
CUSIP: 74291D104
13F Institutional Holders and Ownership History from Q2 2025 to Q2 2026
Institutions Reporting
70
Shares (Excl. Options)
47,755,798
Price
$2.04
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Class A Common Stock
- Symbol
- PROK on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 47,755,798
- Total 13F value
- $97,411,003
- Portfolio coverage rank
- 0%
- Share change
- +5,092,417
- Value change
- +$11,014,270
- Number of holders
- 70
- Shares outstanding
- 205,399,064
- SEC-reported price per share
- $1.54
- Insider filing price
- $1.54
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- PROK - PROKIDNEY CORP. - Class A Common Stock is tracked under CUSIP 74291D104.
- 70 institutions reported positions in Q2 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 69 to 70 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $76,353,029 to $97,411,003.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 70 institutions filings for Q2 2026.
Security key
74291D104
Latest holder period
Q2 2026
13F holders
70
13D/G owners
2
CIK / CUSIP context first
Open Q2 2026 holders
PROK full holder history
PROKIDNEY CORP. SEC filings
PROKIDNEY CORP. company facts
PROKIDNEY CORP. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74291D104:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
PROK
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Control Empresarial de Capitales S.A. de C.V. | 36% | $132,052,942 | 73,842,723 | Control Empresarial de Capitales S.A. de C.V. | 28 Apr 2026 | |||
| MORGAN STANLEY | 4.7% | -22% | $15,542,547 | +$1,825,376 | 9,653,756 | +13% | Morgan Stanley | 30 Jun 2026 |
As of 30 Jun 2026, 70 institutional investors reported holding 47,755,798 shares of PROKIDNEY CORP. - Class A Common Stock (PROK). This represents 23% of the company’s total 205,399,064 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
23%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | 6% | 12,341,266 | 0% | 0.53% | $25,176,183 |
| MORGAN STANLEY | 4.8% | 9,854,178 | +10% | 0% | $20,102,523 |
| BlackRock, Inc. | 2.5% | 5,197,227 | +275% | 0% | $10,602,343 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.2% | 2,390,147 | +94% | 0% | $4,877,226 |
| Bleichroeder LP | 0.97% | 2,000,000 | 0% | 0.73% | $4,080,000 |
| Hennion & Walsh Asset Management, Inc. | 0.9% | 1,847,749 | +15% | 0.11% | $3,769,408 |
| Artia Global Partners LP | 0.88% | 1,806,939 | 0% | 0.7% | $3,686,156 |
| VANGUARD CAPITAL MANAGEMENT LLC | 0.57% | 1,175,257 | +2.5% | 0% | $2,397,524 |
| RENAISSANCE TECHNOLOGIES LLC | 0.54% | 1,099,400 | -12% | 0% | $2,242,776 |
| MILLENNIUM MANAGEMENT LLC | 0.51% | 1,054,705 | -54% | 0% | $2,151,598 |
| STATE STREET CORP | 0.51% | 1,045,945 | +88% | 0% | $2,133,728 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.38% | 781,729 | +25% | 0% | $1,594,727 |
| UBS Group AG | 0.33% | 671,447 | +101% | 0% | $1,369,752 |
| NORTHERN TRUST CORP | 0.32% | 664,827 | +175% | 0% | $1,356,247 |
| MYDA Advisors LLC | 0.31% | 640,775 | +49% | 0.32% | $1,307,181 |
| VANGUARD FIDUCIARY TRUST CO | 0.31% | 632,149 | +17% | 0% | $1,289,584 |
| BANK OF AMERICA CORP /DE/ | 0.27% | 545,158 | -28% | 0% | $1,112,122 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.25% | 517,082 | 0% | $1,054,847 | |
| Voleon Capital Management LP | 0.23% | 473,307 | +361% | 0.02% | $965,546 |
| Amundi | 0.15% | 304,151 | +4.3% | 0% | $620,468 |
| GSA CAPITAL PARTNERS LLP | 0.15% | 301,622 | +48% | 0.04% | $615,000 |
| TWO SIGMA INVESTMENTS, LP | 0.13% | 273,259 | -21% | 0% | $557,448 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.12% | 252,906 | +24% | 0% | $515,928 |
| GOLDMAN SACHS GROUP INC | 0.1% | 203,006 | -52% | 0% | $414,132 |
| Virtus Investment Advisers, LLC | 0.1% | 199,510 | +62% | 0.09% | $407,000 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
5
Latest
Q2 2026
Rows shown
1-5 of 5
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 47,755,798 | $97,411,003 | +$11,014,270 | $2.04 | 70 |
| 2026 Q1 | 42,655,656 | $76,353,029 | +$964,134 | $1.79 | 69 |
| 2025 Q4 | 41,945,569 | $93,958,103 | +$18,974,610 | $2.24 | 62 |
| 2025 Q3 | 33,452,097 | $80,954,450 | +$79,786,213 | $2.42 | 55 |
| 2025 Q2 | 527,620 | $311,428 | +$311,428 | $0.59 | 5 |